Showing 38,381 - 38,400 results of 101,211 for search '(( 5 ht decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.64s Refine Results
  1. 38381
  2. 38382
  3. 38383
  4. 38384
  5. 38385
  6. 38386
  7. 38387
  8. 38388
  9. 38389
  10. 38390

    Thermodynamic parameters. by Jianqing Jia (21001506)

    Published 2025
    “…Consequently, tunnel reliability decreases. Specifically, with temperature increases of 2.6 °C and 4 °C, tunnel reliability decreases by approximately 4.5% and 6.3%, respectively, when considering insulation layer deterioration.…”
  11. 38391

    Alteration of Pituitary Tumor Transforming Gene-1 Regulates Trophoblast Invasion via the Integrin/Rho-Family Signaling Pathway by Seung Mook Lim (2267395)

    Published 2016
    “…Furthermore, knockdown of PTTG1 increased expression of integrin alpha 4 (ITGA4), ITGA5, and integrin beta 1 (ITGB1); otherwise, RhoA expression was significantly decreased (<i>p <</i> 0.05). …”
  12. 38392

    Table_1_Dysregulation of Principal Circulating miRNAs in Non-human Primates Following Ischemic Stroke.XLSX by Jian Chen (15340)

    Published 2021
    “…For example, mml-miR-191-5p, miR-421, miR-409-5p, and let-7g-5p were found to be significantly overexpressed, whereas mml-miR-128a-5p_R − 2, miR-431_R − 1, and let-7g-3p_1ss22CT were significantly downregulated. …”
  13. 38393

    Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016 by Brian J. Piper (412361)

    Published 2018
    “…</p><p>Results</p><p>Amphetamine use increased 2.5 fold from 2006 to 2016 (7.9 to 20.0 tons). Methylphenidate use, at 16.5 tons in 2006, peaked in 2012 (19.4 tons) and subsequently showed a modest decline (18.6 tons in 2016). …”
  14. 38394
  15. 38395
  16. 38396
  17. 38397

    Image_2_A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.tif by James J. Harding (12415627)

    Published 2022
    “…Adult patients with treatment-refractory solid tumors received PF-06671008 (1.5–400 ng/kg) as a weekly intravenous (IV) infusion on a 21-day/3-week cycle. …”
  18. 38398

    Image_1_A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.tif by James J. Harding (12415627)

    Published 2022
    “…Adult patients with treatment-refractory solid tumors received PF-06671008 (1.5–400 ng/kg) as a weekly intravenous (IV) infusion on a 21-day/3-week cycle. …”
  19. 38399

    Imatinib causes a reduction in the size of granulomatous lesions in Mm-infected mice. by Tesia L. Cleverley (15628353)

    Published 2023
    “…A p value > 0.05 was considered not significant (ns).The mean +/- SD, for each group is presented to show the variance in the data.…”
  20. 38400